Karyopharm Therapeutics Inc. (KPTI)
NASDAQ: KPTI · Real-Time Price · USD
6.74
-0.34 (-4.87%)
Sep 4, 2025, 4:00 PM - Market closed
Karyopharm Therapeutics Analyst Ratings
Total Analysts
6
Consensus Rating
Buy
Price Target
$39.80
Upside
+490.94%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Baird | Baird | Buy Maintains $42 → $25 | Buy | Maintains | $42 → $25 | +271.20% | Aug 12, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jul 16, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $27 | Strong Buy | Initiates | $27 | +300.89% | Jul 11, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $34 → $33 | Buy | Maintains | $34 → $33 | +389.98% | May 13, 2025 |
| Barclays | Barclays | Buy Maintains $5 → $10 | Buy | Maintains | $5 → $10 | +48.48% | May 13, 2025 |
| Baird | Baird | Buy Maintains $54 → $42 | Buy | Maintains | $54 → $42 | +523.61% | May 13, 2025 |
| Baird | Baird | Buy Maintains $75 → $54 | Buy | Maintains | $75 → $54 | +701.78% | Mar 3, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $7 → $56 | Strong Buy | Maintains | $7 → $56 | +731.48% | Feb 26, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $45 | Buy | Reiterates | $45 | +568.15% | Feb 20, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $105 | Strong Buy | Reiterates | $105 | +1,459.02% | Feb 20, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $45 | Buy | Reiterates | $45 | +568.15% | Feb 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $105 | Strong Buy | Reiterates | $105 | +1,459.02% | Jan 15, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $60 → $75 | Buy | Maintains | $60 → $75 | +1,013.59% | Nov 6, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $105 | Strong Buy | Reiterates | $105 | +1,459.02% | Nov 6, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $105 | Strong Buy | Reiterates | $105 | +1,459.02% | Nov 1, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $105 | Strong Buy | Reiterates | $105 | +1,459.02% | Aug 7, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.